All Infection Prevention & Control articles – Page 8
-
NewsBreakthrough of the Year: A drug that prevents HIV infection, providing six months of protection per shot
As its 2024 Breakthrough of The Year, Science has named the development of lenacapavir – a promising new injectable drug that prevents HIV infection. The award also recognizes related work surrounding gaining a new understanding of the structure and function of HIV’s capsid protein.
-
NewsStudy shows how genetic defects in Toxoplasma are rescued by co-infection
Toxoplasma gondii parasites can use secreted factors to compensate for genetic defects in neighbouring parasites, highlighting a limitation of pooled CRISPR screens.
-
NewsResearch yields new model for replication of BKPyV virus, a major cause of kidney transplant failure
There are no effective antivirals against BK polyomavirus in transplanted kidneys. A better understanding of its replication will offer new ways to protect those kidneys.
-
NewsCleaning surfaces every two hours cuts norovirus infections by 83% in airports
At airports, frequently disinfecting surfaces, mask-wearing and antimicrobial surface coatings can all help prevent the spread of norovirus, according to a new study.
-
NewsBacterial ‘biopesticide’ against malaria mosquitoes successful in early field tests
An experimental bacteria-derived biopesticide is highly effective in killing malaria-carrying mosquitoes, including those that have developed resistance to chemical pesticides, according to initial field tests.
-
NewsTherapeutic tool inhibits the proliferation of the SARS-CoV-2 virus that causes COVID-19
A study led by the University of Barcelona and the Spanish National Research Council’s Institute for Advanced Chemistry of Catalonia (IQAC - CSIC) presents a new therapeutic tool capable of inhibiting the proliferation of the SARS-CoV-2 virus that causes COVID-19. Source: University of Barcelona The experts Verònica Noé ...
-
NewsThe viral puzzle of why humans are susceptible to hepatitis B - but monkeys are not
Scientists collaborated to reveal the structural features of hepatitis B viral receptor homologue in macaques that restrict viral entry into their cells.
-
NewsNanorobot hand made of DNA grabs viruses for diagnostics and blocks cell entry
A tiny, four-fingered ‘hand’ folded from a single piece of DNA can pick up the virus that causes COVID-19 for highly sensitive rapid detection and can even block viral particles from entering cells to infect them.
-
NewsResearchers develop lysosomal TRAP for clearance of viruses and variants
Researchers have developed a novel lysosomal strategy for clearing viruses and their variants. This lysosomal ‘TRAP’ (lysoTRAP) shows potential for inhibiting infection by viruses and variants in cell, mouse, hamster, and human lung organoid models.
-
NewsPhotodynamic therapy with annatto colorant found to be effective against bad breath
A study by researchers working in Brazil shows that antimicrobial photodynamic therapy in which blue light targets annatto colorant is a feasible and effective option for treatment of halitosis in mouth-breathing children.
-
NewsUsing antibiotics alone to treat children with appendicitis is a cost-effective and safe alternative to surgery
An analysis of data from more than 1,000 children with uncomplicated acute appendicitis found an antibiotics-only approach resulted in less pain and fewer days off from school during the first year after the initial hospital visit.
-
NewsResearchers find that intestinal infections change bile composition
Intestinal infections can change the composition of liver bile, leading to changes in immune function and gut bacteria, potentially helping fight off harmful bacteria.
-
NewsHot water best for sanitizing in-shell pecans, sanitizers prevent cross-contamination
To identify best practices for microbial safety in the pecan market, scientists conducted a study to evaluate methods of sanitizing pecans against Shiga toxin-producing E. coli, also known as STEC.
-
NewsAntibiotics initiated for suspected community-acquired pneumonia even when chest radiography results are negative
A new study shows that many general practitioners prescribe antibiotics for suspected community-acquired pneumonia even when chest X-ray results are negative, highlighting a gap between guidelines and actual practice.
-
NewsArtificial intelligence can be used to treat infections more accurately
New research has shown that using artificial intelligence (AI) can improve how we treat urinary tract infections (UTIs), and help to address antimicrobial resistance (AMR).
-
NewsStudy uncovers key heart responses to viral infection
Researchers at the University of Virginia have made a significant discovery that could change how doctors treat viral infections of the heart. Source: UVA Engineering Kevin Janes, University of Virginia John Marshall Money Professor, Department of Biomedical Engineering and Department of Biochemistry & Molecular Genetics. The ...
-
NewsScientist developing probiotics to combat bovine respiratory disease
A new research project aims to develop probiotics derived from healthy cattle to prevent bovine respiratory disease, which is estimated to be responsible for about 70 to 80 percent of feedlot illnesses, and between 40 and 50 percent of all feedlot deaths in the US.
-
Careers‘It’s been an eye-opener’: Thomas Thompson on his year as a Junior Editor
One year into our first Junior Editor training programme with Letters in Applied Microbiology, Dr Thomas Thompson of Queen’s University Belfast tells us how he is getting on.
-
NewsResearchers reveal HIV latency reversing properties in African plant
Scientists have uncovered mechanisms of a medicinal plant with anti-HIV potential. Croton oligandrus Pierre & Hutch is a species of tree used in traditional healing in Cameroon to treat a variety of diseases and conditions including cancers and diabetes.
-
NewsTherapeutic proven to reduce advanced-stage influenza viral loads faster, more thoroughly in preclinical studies
Eradivir, a preclinical biotech company, has developed a patent-pending antiviral therapeutic that reduces lung viral loads of advanced-stage influenza in preclinical studies quicker and more effectively than currently available therapies.